Chris Hadsall became Chief Operating Officer of Reginicin Inc. in October 2010. In this position, his main duty is to supervise government affairs. When he was hired, CEO of the company, Randall McCoy said, “we are extremely pleased to have Chris join our management team. His strong operational background, along with his proven ability to make a meaningful impact within large care organizations, make him the perfect choice. I look forward to working together with Chris as we build the foundation for Regenicin™’s promising future.” In his own words, on deciding to take on this role at Reginicin, Hadsall explained, “having served in the military and working with wounded veterans over the course of the last 12 years, I am keenly aware of the tremendous benefits of Regenicin™’s PermaDerm™ products for treating wounded soldiers as well as other victims of serious burns or injuries requiring grafting. I am looking forward to applying my operational management skills along with my expertise in working with hospitals and care organizations to help Regenicin™ realize its huge growth potential.”